Research on the role and mechanism of SLC7A5 in idiopathic pulmonary fibrosis
Molecular Medicine Reports · 2026
DOI: 10.3892/mmr.2026.14034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Medicine Reports, 2026. Verfasst von Menghan Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, P.R. Ch…. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Minor Histocompatibility Antigens, Amino Acid Transport System y+. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) is a progressive, chronic and fatal interstitial lung disease. The etiology of IPF remains to be fully elucidated and its prognosis remains poor with a short survival period. Solute carrier family 7 member 5 (SLC7A5) is an amino acid transporter that is responsible for the transportation of large neutral amino acids. The expression of SLC7A5 was found to be significantly upregulated in patients with IPF, as well as in the lung tissues of mice with bleomycin (BLM)‑induced pulmonary fibrosis and in human lung fibroblasts induced by transforming growth factor‑β1 (TGF‑β1). Both SLC7A5 knockdown and the use of the selective SLC7A5 inhibitor JPH203 affected the function of TGF‑β1‑induced myofibroblasts by inhibiting the PI3K/AKT/mTOR pathway. In vivo, JPH203 improved BLM‑induced pulmonary fibrosis in mice by inhibiting the activation of the PI3K/AKT/mTOR signaling pathway. Therefore, SLC7A5 may represent a new therapeutic target for IPF. Future research should focus on therapeutic strategies regulating this target for translation into potential effective treatments for IPF in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, P.R. China.
- Department of Respiratory Medicine, Heilongjiang Provincial Hospital, Harbin, Heilongjiang 150001, P.R. China.
- NHC Key Laboratory of Cell Transplantation, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.
Zitieren
APA
Wang, M., Yu, Y., Liu, Z., Xu, D., Li, Y., Zou, X., Shan, N., Liu, X., Shi, C., & Chen, H. (2026). Research on the role and mechanism of SLC7A5 in idiopathic pulmonary fibrosis. Molecular Medicine Reports. https://doi.org/10.3892/mmr.2026.14034
Vancouver
Wang M, Yu Y, Liu Z, Xu D, Li Y, Zou X, et al. Research on the role and mechanism of SLC7A5 in idiopathic pulmonary fibrosis. Molecular Medicine Reports. 2026. doi:10.3892/mmr.2026.14034
BibTeX
@article{Wang2026,
author = {Wang, Menghan and Yu, Yao and Liu, Zhaoyu and Xu, Dandan and Li, Yupeng and Zou, Xing and Shan, Ning and Liu, Xining and Shi, Ce and Chen, Hong},
title = {Research on the role and mechanism of SLC7A5 in idiopathic pulmonary fibrosis},
journal = {Molecular Medicine Reports},
year = {2026},
doi = {10.3892/mmr.2026.14034}
}
EUVIMED